Caris Life Sciences (CAI) Cash from Operations (2024 - 2026)
Caris Life Sciences (CAI) recorded quarterly Cash from Operations of 32876000.0 in Q1 2026, down 26.58% quarter-over-quarter from 44780000.0 in Q4 2025, and up 204.91% on a YoY basis from 10782276.54 in Q1 2025.
Caris Life Sciences (CAI) Cash from Operations (2024 - 2026) Analysis & Trends
Caris Life Sciences' Cash from Operations history runs 3 years deep, the most recent figure standing at 32876000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 204.91% year-over-year to 32876000.0; the TTM figure through Mar 2026 stood at 147369000.0 (changed N/A YoY), while the FY2025 annual figure was 83155000.0, up 133.91% from the prior year.
- Cash from Operations was 32876000.0 for Q1 2026 at Caris Life Sciences, down from 44780000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 62425000.0 in Q3 2025 to a low of 69427000.0 in Q3 2024.
- Historically, Cash from Operations has averaged 1097571.43 across 3 years, with a median of 7288000.0 in 2025.
- Biggest YoY gain for Cash from Operations was 215.05% in 2025; the steepest drop was 189.91% in 2025.
- A 3-year view of Cash from Operations shows it stood at 38921000.0 in 2024, then surged by 215.05% to 44780000.0 in 2025, then declined by 26.58% to 32876000.0 in 2026.
- The last three Cash from Operations figures came in at 32876000.0 (Q1 2026), 44780000.0 (Q4 2025), and 62425000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Caris Life Sciences | 5.22 Bn | 4.40 Bn | 171.13 Mn | 32.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.88 Mn |
| Mar 31, 2026 | 32.88 Mn |
| Dec 31, 2025 | 44.78 Mn |
| Dec 31, 2025 | 44.78 Mn |
| Sep 30, 2025 | 62.43 Mn |
| Sep 30, 2025 | 62.43 Mn |
| Jun 30, 2025 | 7.29 Mn |
| Jun 30, 2025 | 7.29 Mn |
| Mar 31, 2025 | -31.34 Mn |
| Mar 31, 2025 | -31.34 Mn |
| Dec 31, 2024 | -38.92 Mn |
| Dec 31, 2024 | -38.92 Mn |
| Sep 30, 2024 | -69.43 Mn |
| Sep 30, 2024 | -69.43 Mn |